Machine learning helps in predicting when immunotherapy will be effective

Cancer cells can put the body's immune cells into sleep mode. Immunotherapy can reverse this, but it doesn't work for all patients and all cancer types. Researchers at TU/e have developed machine learning models that can predict if someone is likely to respond positively to immunotherapy. In clinical settings, this could pave the way for personalized immunotherapy approaches for patients, as well as guidance on how to best combine immunotherapy with other treatments.